<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2024.86.20</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТОЧКА ЗРЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>POINT OF VIEW</subject></subj-group></article-categories><title-group><article-title>Отношение показателя нейтрофилов к лимфоцитам и апоптоз лимфоцитов у больных HBV и HCV в зависимости от стадии фиброза печени</article-title><trans-title-group xml:lang="en"><trans-title>Ratio of neutrophils to lymphocytes and apoptosis of lymphocytes in patients with HBV and HCV depending on the stage of liver fibrosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9227-5743</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фараджева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Faradzheva</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фараджева Натаван Алыш кызы – д.м.н., проф.</p></bio><bio xml:lang="en"><p>Faradzheva Natavan Alysh kizi – Doctor of Medical Sciences, Professor, Department of Therapy</p></bio><email xlink:type="simple">nnatavan_n@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Махмудова</surname><given-names>К. Дж.</given-names></name><name name-style="western" xml:lang="en"><surname>Mahmudova</surname><given-names>K. J.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Махмудова Конуль Джахангир кызы – врач-терапевт</p><p>Баку</p></bio><bio xml:lang="en"><p>Mahmudova Konul Jahangir kizi – therapist.</p><p>Baku</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахмедова</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ahmedova</surname><given-names>L. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ахмедова Лeйли Мaмед кызы – к.м.н., с.н.с. Центральной науч.-исслед. лаб. Азербайджанского ГИУВ им. А. Алиева</p></bio><bio xml:lang="en"><p>Ahmadova Leyli Mamed kizi – PhD in Medicine, Senior Researcher at the Central Research Laboratory</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Азербайджанский гос. ин-т усоверш. врачей им. А. Алиева</institution><country>Азербайджан</country></aff><aff xml:lang="en"><institution>A.	Aliyev Azerbaijan State Institute of Advanced Medical Education</institution><country>Azerbaijan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медицинский центр “Medikus Сlinic”</institution><country>Азербайджан</country></aff><aff xml:lang="en"><institution>Medikus Clinic' Medical Center</institution><country>Azerbaijan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>2</issue><fpage>84</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фараджева Н.А., Махмудова К.Д., Ахмедова Л.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Фараджева Н.А., Махмудова К.Д., Ахмедова Л.М.</copyright-holder><copyright-holder xml:lang="en">Faradzheva N.A., Mahmudova K.J., Ahmedova L.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/291">https://ymj.elpub.ru/jour/article/view/291</self-uri><abstract><p>Частым осложнением HBV и HCV является цирроз печени, в основе которого стоит хроническое системное воспаление, связанное с иммунной дисфункцией, влияющей на прогрессирование заболевания. Целью исследования было определение отношения нейтрофилов к лимфоцитам (ОНЛ) и показателя апоптоза лимфоцитов как маркера степени воспаления и системного иммуновоспалительного ответа при различных степенях фиброза печени у больных с HBV и HCV. Полученные результаты показали повышение абсолютного числа лимфоцитов со снижением показателя ОНЛ на фоне снижения маркера апоптоза лимфоцитов СВ95+ с различными степенями фиброза печени. Снижение этого маркера отражает повреждающее действие гепатотропных вирусов, косвенным подтверждением чего и является выявленный лейкоцитоз.</p></abstract><trans-abstract xml:lang="en"><p>A common complication of HBV and HCV is liver cirrhosis, which is based on chronic systemic inflammation associated with immune dysfunction that affects the progression of the disease.</p><sec><title>The purpose of the study</title><p>The purpose of the study. Determination of NLR and lymphocyte apoptosis index as a marker of the degree of inflammation and systemic immuno-inflammatory response in various degrees of liver fibrosis in patients with viral hepatitis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 107 patients underwent the study, of which 53 patients were diagnosed with HBV and 54 with HCV. The blood levels of leukocytes, neutrophils, and lymphocytes were studied in the studied patients and the neutrophil/lymphocyte ratio (NEU/LYM) was determined. In order to verify structural changes in the liver, ultrasound elastometric examination was performed on a 2D – Supersonic Aixplorer SWE device (France) for all persons with esTableished viral hepatitis. The examination of patients was carried out according to the Cut–off scale, and liver fibrosis was determined by the METAVIR scale. A group of 10 practically healthy individuals was selected as a comparison group. The values of the indicators were expressed in kPa, the value of the indicator 7.1 kPa corresponded to F2, 9.2 kPa – F3, F4≥13.5 kPa. Verification of HBV and HCV was carried out by PCR on the device “Rotor Qene Q” (Germa</p><p>The results obtained showed an increase in the absolute number of lymphocytes with a decrease in the NLR indicator against the background of a decrease in the apoptosis marker of CB95+ lymphocytes with varying degrees of liver fibrosis. A decrease in this marker reflects the damaging effect of hepatotropic viruses, which is indirectly confirmed by the detected leukocytosis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>вирусный гепатит</kwd><kwd>цирроз печени</kwd><kwd>системное воспаление</kwd><kwd>отношение нейтрофилов к лимфоцитам</kwd></kwd-group><kwd-group xml:lang="en"><kwd>viral hepatitis</kwd><kwd>liver cirrhosis</kwd><kwd>systemic inflammation</kwd><kwd>neutrophil to lymphocyte ratio</kwd><kwd>prognostic marker</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Буеверов А.О., Маевская М.В. Клиническое значение апоптоза при хронических вирусных гепатитах //Медицинский вестник Северного Кавказа. 2009. №2. С.4-9. УДК 616.36–002.2:576.858:616.98</mixed-citation><mixed-citation xml:lang="en">Bueverov A.O., Mayevskaya M.V. Clinical significance of apoptosis in chronic viral hepatitis // Medical Bulletin of the North Caucasus. 2009. No.2. Р. 4-9. УДК 616.36–002.2:576.858:616.98</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Калюжин О.В., Понежева Ж.Б., Семенова И.В. и др. Субпопуляции лимфоцитов, уровень интерферонов и экспрессия их рецепторов у больных хроническими гепатитами В и С: зависимость от вида вирусов м степени фиброза печени //Терапевтич. архив. 2017. №11. С.14-20. doi.org/10.17116/terarkh2017891114-20.</mixed-citation><mixed-citation xml:lang="en">Kalyuzhin O.V., Ponezheva J.B., Semenova I.V., etc. Lymphocyte subpopulations, interferon levels and expression of their receptors in patients with chronic hepatitis B and C: dependence on the type of viruses and degree of liver fibrosis //Therapeutic Archive. 2017. No.11. Р.14-20. doi.org/10.17116/terarkh2017891114-20.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Луньков В.Д., Маевская М.В., Цветаева Е.К. и др. Отношение нейтрофилов к лимфоцитам как предиктор неблагоприятного исхода у пациентов с декомпенсированным циррозом печени //Росс. журнал гастроэнтрологии, гепатологии. 2019. 29(1). С. 47-61. doi.org/10.22416/1382-4376-2019-29-1-47-61.</mixed-citation><mixed-citation xml:lang="en">Lunkov V.D., Mayevskaya M.V., Tsvetaeva E.K., etc. The ratio of neutrophils to lymphocytes as a predictor of an unfavorable outcome in patients with decompensated cirrhosis of the liver //Ross. journal of Gastroenterology, Hepatology, 2019, 29(1); 47-61. doi.org/10.22416/1382-4376-2019-29-1-47-61.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Маннова И.В. Клинико-патогенетическое значение иммунного статуса в формировании фиброза печени у больных хроническим гепатитом С: автореф. дис…. канд. мед. наук. М., 2019. 24 с.</mixed-citation><mixed-citation xml:lang="en">Mannova I.V. Clinical and pathogenetic significance of the immune status in the formation of liver fibrosis in patients with chronic hepatitis C: Abstract of the dissertation, PhD. 2019. 24 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Саркарова М.Р., Маевская М.В. Прогностическое и диагностическое значение показателя отношения нейтрофилов к лимфоцитам у пациентов с заболеваниями желудочно-кишечного тракта и печени // Медицинский совет. 2022. 16(7). С. 60–68. doi.org/10.21518/2079-701X-2022-16-7-60-68.</mixed-citation><mixed-citation xml:lang="en">Sarkarova M.R., Mayevskaya M.V. Prognostic and diagnostic significance of the ratio of neutrophils to lymphocytes in patients with diseases of the gastrointestinal tract and liver // Medical advice, 2022;16(7):60-68. doi.org/10.21518/2079-701X-2022-16-7-60-68.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance //J Hepatol., 2014;61:1385-1396. doi:10.1016/j.jhep.2014.08.010.</mixed-citation><mixed-citation xml:lang="en">Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance //J Hepatol., 2014;61:1385-1396. doi:10.1016/j.jhep.2014.08.010.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Asrani S.K, Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world // J Hepatol. 2019;70(1):151-71. https://doi.org/10.1016/j.jhep.2018.09.014.</mixed-citation><mixed-citation xml:lang="en">Asrani S.K, Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world // J Hepatol. 2019;70(1):151-71. https://doi.org/10.1016/j.jhep.2018.09.014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acuteon-chronic liver failure //Medicine (Baltimore) 2018; 97 :e13324. doi: 10.1097/MD.0000000000013324.</mixed-citation><mixed-citation xml:lang="en">Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acuteon-chronic liver failure //Medicine (Baltimore) 2018; 97 :e13324. doi: 10.1097/MD.0000000000013324.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chiriac S., Stanciu C., Singeap AM, Sfarti C.V. et al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acuteon-chronic liver failure // Turk J Gastroenterol., 2020; 31(12): 868–876. doi: 10.5152/tjg.2020.19838.</mixed-citation><mixed-citation xml:lang="en">Chiriac S., Stanciu C., Singeap AM, Sfarti C.V. et al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acuteon-chronic liver failure // Turk J Gastroenterol., 2020; 31(12): 868–876. doi: 10.5152/tjg.2020.19838.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hashemi S.J., Tosi M.S., Hajiani E. et. al., The Association Between Peripheral Blood Neutrophil-to-Lymphocyte Ratio and Cirrhosis Complications in Adults with Compensated Liver Cirrhosis in Ahvaz, Iran //Shiraz E-Med J.,2023;24(8):e138859. doi.org/10.5812/semj-138859.</mixed-citation><mixed-citation xml:lang="en">Hashemi S.J., Tosi M.S., Hajiani E. et. al., The Association Between Peripheral Blood Neutrophil-to-Lymphocyte Ratio and Cirrhosis Complications in Adults with Compensated Liver Cirrhosis in Ahvaz, Iran //Shiraz E-Med J.,2023;24(8):e138859. doi.org/10.5812/semj-138859.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune response //Front Immunol. 2022; Nov 17:13:1075916. doi:10.3389/fimmu.2022.1075916.</mixed-citation><mixed-citation xml:lang="en">Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune response //Front Immunol. 2022; Nov 17:13:1075916. doi:10.3389/fimmu.2022.1075916.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis // BMC Gastroenterol. 2015;15:146.</mixed-citation><mixed-citation xml:lang="en">Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis // BMC Gastroenterol. 2015;15:146.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Moreau R., Jalan R., Gines P. et al. Acuteon-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis // Gastroenterology, 2013;144:1426–37. doi:10.1053/j.gastro.2013.02.042.</mixed-citation><mixed-citation xml:lang="en">Moreau R., Jalan R., Gines P. et al. Acuteon-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis // Gastroenterology, 2013;144:1426–37. doi:10.1053/j.gastro.2013.02.042.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Noor MT, Manoria P. Immune Dysfunction in Cirrhosis //J Clin Transl Hepatol., 2017;5:50-58. doi: 10.14218/JCTH.2016.00056.</mixed-citation><mixed-citation xml:lang="en">Noor MT, Manoria P. Immune Dysfunction in Cirrhosis //J Clin Transl Hepatol., 2017;5:50-58. doi: 10.14218/JCTH.2016.00056.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Y., Li Y., He Y. et. al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review // Expert Rev Gastroenterol Hepatol., 2018;12 (5):503–513. https://doi.org/10.1080/17474124.2018. 1463158</mixed-citation><mixed-citation xml:lang="en">Peng Y., Li Y., He Y. et. al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review // Expert Rev Gastroenterol Hepatol., 2018;12 (5):503–513. https://doi.org/10.1080/17474124.2018.1463158</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Štimac D., Nardone G., Mazzari A., et al. What’s New in Diagnosing Diverticular Disease // Journal of Gastrointestinal and Liver Diseases. - 2019, Dec19. 28 (4). р. 17-22. doi: 10.15403/jgld-553.</mixed-citation><mixed-citation xml:lang="en">Štimac D., Nardone G., Mazzari A., et al. What’s New in Diagnosing Diverticular Disease // Journal of Gastrointestinal and Liver Diseases. - 2019, Dec19. 28 (4). р. 17-22. doi: 10.15403/jgld-553.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Hepatitis В (2022). Available at: https://www.who.int/newsroom/fact-sheets/detail/hepatitis-b (Accessed October 21, 2022).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Hepatitis В (2022). Available at: https://www.who.int/newsroom/fact-sheets/detail/hepatitis-b (Accessed October 21, 2022).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Xue TC, Zhang L, Xie XY, Ge NL, Li LX, Zhang BH, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: A meta-analysis //PLoS One. 2014;9(5). e96072. https://doi.org/10.1371/journal.pone.0096072.</mixed-citation><mixed-citation xml:lang="en">Xue TC, Zhang L, Xie XY, Ge NL, Li LX, Zhang BH, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: A meta-analysis //PLoS One. 2014;9(5). e96072. https://doi.org/10.1371/journal.pone.0096072.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Feng G, Zhao Y, Zhang J, Feng L, Yang J. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study // BMJ Open, 2015; 5: e008033. doi: 10.1136/bmjopen-2015-008033.</mixed-citation><mixed-citation xml:lang="en">Zhang J, Feng G, Zhao Y, Zhang J, Feng L, Yang J. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study // BMJ Open, 2015; 5: e008033. doi: 10.1136/bmjopen-2015-008033.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Aryan M., Chen Z. et. al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt // Eur J Gastroenterol Hepatol. 2022 Apr 1;34(4):435-442. doi: 10.1097/MEG.0000000000002295.</mixed-citation><mixed-citation xml:lang="en">Zhang W., Aryan M., Chen Z. et. al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt // Eur J Gastroenterol Hepatol. 2022 Apr 1;34(4):435-442. doi: 10.1097/MEG.0000000000002295.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
